Phase 1b/2a randomized study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with chronic hepatitis B

التفاصيل البيبلوغرافية
العنوان:	Phase 1b/2a randomized study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with chronic hepatitis B
المؤلفون:	Tak, W.Y., W-L, Chuang, C-Y, Chen, K-C, Tseng, Y-S, Lim, G-H, Lo, Heo, J., Agarwal, K., Bussey, L., Teoh, S.L., Tria, A., Brown, A., Anderson, K., Vardeu, A., O’Brien, S., Kopycinski, J., Rutkowski, K., Kolenovska, R., Barnes, E., Evans, T.G.
المصدر:	In Journal of Hepatology June 2024
قاعدة البيانات:	ScienceDirect

كن أول من يترك تعليقا!